Table 2.
Vitamin D receptor immunohistochemical staining analysis in patients with gestational trophoblastic neoplasia or hydatidiform mole.
Diagnosis |
||
---|---|---|
Gestational trophoblastic neoplasia (n = 24) | Hydatidiform mole (n = 37) | |
VDR intensity | ||
Weak | 6 (25.0%) | 2 (5.4%) |
Moderate | 6 (25.0%) | 5 (13.6%) |
Strong | 12 (50.0%) | 30 (81.0%) |
VDR distribution | ||
≤10% | 0 (0.0%) | 3 (8.1%) |
11–50% | 4 (16.7%) | 4 (10.8%) |
51–80% | 9 (37.5%) | 8 (21.7%) |
>81% | 11 (45.8%) | 22 (59.4%) |
VDR, vitamin D receptor.